| Instrumental Speech Language Pathology Professionals Inc. | |
|
5475 E La Palma Ave Ste 206, Anaheim, CA 92807-2075 | |
| (714) 922-5235 | |
| Not Available |
| Full Name | Instrumental Speech Language Pathology Professionals Inc. |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 5475 E La Palma Ave Ste 206, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396372686 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Lyda Kongswangwongsa |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1891183422 PECOS PAC ID: 5294156816 Enrollment ID: I20200623001492 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Kathryn Woolley |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1144834391 PECOS PAC ID: 7810316684 Enrollment ID: I20200928001771 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Stacey Huang |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1306206750 PECOS PAC ID: 5193121085 Enrollment ID: I20210901000033 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Theresa Thuy Dacio |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1285386920 PECOS PAC ID: 1456744465 Enrollment ID: I20220215000316 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Amy Deeb |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1073007852 PECOS PAC ID: 1254707060 Enrollment ID: I20221019002715 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Nicole A Holman |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1770191769 PECOS PAC ID: 0547633125 Enrollment ID: I20230301001641 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Provider Name | Kimberly Hernandez |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1275096117 PECOS PAC ID: 8820450646 Enrollment ID: I20230810003170 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Instrumental Speech Language Pathology Professionals Inc. 5475 E La Palma Ave Ste 206, Anaheim, CA 92807-2075 Ph: (714) 922-5235 | Instrumental Speech Language Pathology Professionals Inc. 5475 E La Palma Ave Ste 206, Anaheim, CA 92807-2075 Ph: (714) 922-5235 |
News Archive
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
New research led by the Hip Implant Prosthesis Study team at the University of Bristol Medical School has shown that small-head cemented metal-on-plastic hip replacements are the most cost-effective in men and women older than 65 years.
Scientists at the Oregon National Primate Research Center today revealed that infant rhesus macaques treated with antibodies within 24 hours of being exposed to SHIV, a chimeric simian virus that bears the HIV envelope protein, were completely cleared of the virus.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
› Verified 2 days ago
Kentessa Birner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 160 S Old Springs Rd, Suite 100, Anaheim, CA 92808 Phone: 714-282-8852 Fax: 714-282-8876 | |
Ms. Sarah Yi, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 | |
Elizabeth Welsh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1360 S Anaheim Blvd Ste 150, Anaheim, CA 92805 Phone: 714-776-1231 | |
Ms. Deborah Fung Wai Lau, M.A.. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 Fax: 714-776-0802 | |
Katelyn Dean, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2717 E Maverick Ave, Anaheim, CA 92806 Phone: 714-350-1942 | |
Nicole Versales, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 S Chaparral Ct Ste 110, Anaheim, CA 92808 Phone: 714-282-8852 Fax: 714-282-8876 | |
Eun Hwa Lee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 Fax: 714-776-0802 |